Stephen Glasser
Internal Medicine · Baltimore, MDNPI 1912073214
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,237 of the $3,751 with a category attached, or 86.3%. It is spread thinly across 32 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,172 and has fallen 98.1% since, to $23 in 2025.
Across 149 payments — averaging $25.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$382
- Johnson & Johnson$361
- AstraZeneca$323
- Amgen$271
- Novo Nordisk$268
- Novartis$267
- plus $2K from 26 others
What the payments were for
- Consulting fees$48813%
- Food & beverage$3,23786%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 3 | $382 |
| Johnson & Johnson | 13 | $361 |
| AstraZeneca | 8 | $323 |
| Amgen(2 entities) | 14 | $271 |
| Novo Nordisk | 11 | $268 |
| Novartis | 10 | $267 |
| Pfizer | 10 | $254 |
| AbbVie(2 entities) | 13 | $218 |
| Lilly USA, LLC | 11 | $200 |
| Tersera Therapeutics LLC | 1 | $163 |
| Amarin Pharma, Inc. | 6 | $128 |
| GSK | 3 | $128 |
| Kowa Pharmaceuticals America, Inc. | 8 | $109 |
| Astellas Pharma US Inc | 6 | $101 |
| Merck | 5 | $65 |
| Esperion Therapeutics, Inc. | 3 | $58 |
| Boehringer Ingelheim | 2 | $52 |
| E.r. Squibb & Sons, L.L.C. | 3 | $42 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $38 |
| Amneal Pharmaceuticals LLC | 2 | $37 |
| Boston Scientific | 1 | $37 |
| Endo Pharmaceuticals Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Coopervision Inc. | 1 | $23 |
| Exelixis Inc. | 1 | $22 |
| Medicure Pharma Inc. | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $16 |
| IBSA Pharma Inc. | 1 | $15 |
| Abbott | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,751 in reported general payments places this provider in the 85th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Baltimore
- Param DedhiaBaltimore$636K
- Shawn DhillonBaltimore$227K
- Jeremy SugarmanBaltimore$210K
- Charles FlexnerBaltimore$133K
- Kristen MarroneBaltimore$97K
- Ana-Maria OrbaiBaltimore$89K
- Mark YarchoanBaltimore$89K
- David Muniz PedrogoBaltimore$82K
- Julie PaikBaltimore$76K
- Allison AgwuBaltimore$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.